Literature DB >> 12054170

Leptin receptor (OB-R) gene expression in human primary osteoblasts: confirmation.

A Enjuanes, A Supervía, X Nogués, A Díez-Pérez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12054170     DOI： 10.1359/jbmr.2002.17.6.1135

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  7 in total

Review 1.  The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.

Authors:  H Sadie-Van Gijsen; N J Crowther; F S Hough; W F Ferris
Journal:  Cell Mol Life Sci       Date:  2012-11-21       Impact factor: 9.261

Review 2.  Bone Cell Bioenergetics and Skeletal Energy Homeostasis.

Authors:  Ryan C Riddle; Thomas L Clemens
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 3.  How to grow bone to treat osteoporosis and mend fractures.

Authors:  James F Whitfield
Journal:  Curr Osteoporos Rep       Date:  2003-06       Impact factor: 5.096

4.  Peripheral leptin regulates bone formation.

Authors:  Russell T Turner; Satya P Kalra; Carmen P Wong; Kenneth A Philbrick; Laurence B Lindenmaier; Stephane Boghossian; Urszula T Iwaniec
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

Review 5.  Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.

Authors:  Ricardo A Battaglino; Antonio A Lazzari; Eric Garshick; Leslie R Morse
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

6.  Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.

Authors:  Ashley L Doherty; Ricardo A Battaglino; Jayne Donovan; David Gagnon; Antonio A Lazzari; Eric Garshick; Ross Zafonte; Leslie R Morse
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

Review 7.  How to grow bone to treat osteoporosis and mend fractures.

Authors:  James F Whitfield
Journal:  Curr Rheumatol Rep       Date:  2003-02       Impact factor: 4.686
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.